- Home
- GHRS vs DCBO Comparison
GHRS vs DCBO Comparison
Compare GHRS & DCBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHRS
- DCBO
- Stock Information
- Founded
- GHRS 2018
- DCBO 2016
- Country
- GHRS Ireland
- DCBO Canada
- Employees
- GHRS N/A
- DCBO N/A
- Industry
- GHRS Biotechnology: Pharmaceutical Preparations
- DCBO
- Sector
- GHRS Health Care
- DCBO
- Exchange
- GHRS Nasdaq
- DCBO Nasdaq
- Market Cap
- GHRS 892.0M
- DCBO 723.3M
- IPO Year
- GHRS 2021
- DCBO 2020
- Fundamental
- Price
- GHRS $14.38
- DCBO $21.13
- Analyst Decision
- GHRS Strong Buy
- DCBO Buy
- Analyst Count
- GHRS 9
- DCBO 7
- Target Price
- GHRS $30.11
- DCBO $35.57
- AVG Volume (30 Days)
- GHRS 407.8K
- DCBO 94.6K
- Earning Date
- GHRS 11-06-2025
- DCBO 11-07-2025
- Dividend Yield
- GHRS N/A
- DCBO N/A
- EPS Growth
- GHRS N/A
- DCBO 32.42
- EPS
- GHRS N/A
- DCBO 0.74
- Revenue
- GHRS N/A
- DCBO $236,691,000.00
- Revenue This Year
- GHRS N/A
- DCBO $13.00
- Revenue Next Year
- GHRS N/A
- DCBO $8.37
- P/E Ratio
- GHRS N/A
- DCBO $28.66
- Revenue Growth
- GHRS N/A
- DCBO 13.16
- 52 Week Low
- GHRS $6.72
- DCBO $20.20
- 52 Week High
- GHRS $20.50
- DCBO $50.80
- Technical
- Relative Strength Index (RSI)
- GHRS 55.96
- DCBO 28.32
- Support Level
- GHRS $13.71
- DCBO $20.26
- Resistance Level
- GHRS $15.01
- DCBO $21.29
- Average True Range (ATR)
- GHRS 0.98
- DCBO 1.17
- MACD
- GHRS 0.04
- DCBO -0.16
- Stochastic Oscillator
- GHRS 74.17
- DCBO 14.47
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
About DCBO Docebo Inc.
Docebo Inc is a provider of cloud-based learning management systems. The solutions provided by the company allow learning administrators to deliver scalable and flexible personalized learning experiences, from formal training to social learning to multiple internal, external, and blended audiences. The group provides an easy-to-use, configurable, and affordable learning platform with the end-to-end capabilities and critical functionality needed to train both internal and external workforces, partners, and customers. The majority of the revenue is derived from customers based in North America.